Table IV.

Frequency distribution of all significantly differentially methylated CpG sites between acute coronary syndrome and control samples by methylation status.

ACS vs. control group methylation β score difference (%)	Hypermethylated CpG sites, n (%)	Cumulative (%)	Hypomethylated CpG sites, n (%)	Cumulative (%)
≥50	24 (0.97)	0.97	16 (0.18)	0.18
≥40–<50	32 (1.29)	2.26	22 (0.25)	0.43
≥30–<40	35 (1.41)	3.67	40 (0.45)	0.88
≥20–<30	133 (5.37)	9.04	904 (10.20)	11.08
≥10–<20	2,253 (90.96)	100	7,883 (88.92)	100
Total	2,477	–	8,865	–

CpG, 5′-C-phosphate-G-3′; ACS, acute coronary syndrome.